Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT01711658 2023-10-17

TRYHARD

Phase 2 Completed

142 enrolled 22 charts

Head & Neck

Head and Neck Neoplasms

NCT00498953 2018-07-09

Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx

Phase 1/2 Completed

7 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00095563 2017-04-18

Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers

Phase 2 Completed

40 enrolled 9 charts

Head & Neck

Salivary Gland Neoplasms

NCT00387127 2015-06-25

Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer

Phase 2 Completed

67 enrolled 18 charts

Head & Neck

Head and Neck Neoplasms

NCT00114283 2015-04-15

Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Phase 2 Completed

30 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT00424255 2014-07-18

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Phase 3 Completed

688 enrolled 19 charts

Head & Neck

Head and Neck Neoplasms

NCT00098631 2014-01-07

Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Phase 2 Completed

88 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00371566 2010-04-06

A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer

Phase 2 Completed

107 enrolled 34 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

Clinical Trials

Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery

TRYHARD

Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx

Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers

Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer

Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer